1[1]WHO/Switzerland.World health day.Safe Motherhood,1998 被引量：1
2[3]Anne T.Safe motherhood is a vital social and economic investment-presentation at safe motherhood technical consultant in 18～23 Oct.Colombo, Sri Lanka,1997 被引量：1
3[4]Win Van Lerberghe.A historical perspective on maternal mortality reduction-presentation at safe motherhood technical consultant in 18～23 Oct.Colombo, Sri Lanka,1997 被引量：1
4[5]Margaret P.Ensure skill attendance at delivery.International conference of midwives,Australia.Presentation at safe motherhood technical consultant in 18～23 Oct.Colombo,Sri Lanka,1997 被引量：1
5[1]Stan C,Boulvain M,Hirsbrunner-Amagbaly P,et al.Hydration for treatment of preterm labour(Cochrane Review).In:The Cochrane Library.Oxford:Update Software,2002. 被引量：1
6[2]Mittendorf R,Dambrosia J,Pryde PG,et al.Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.Am J Obstet Gynecol,2002,186(6):1111 被引量：1
7[3]King JF,Flenady VJ,Papatsonis DNM,et al.Calcium channel blockers for inhibiting preterm labour (Cochrane Review).In:The Cochrane Library.Oxford:Update Software,2002. 被引量：1
8[4]Tsatsaris V,Papatsonis D,Goffinet F,et al.Tocolysis with nifedipine or beta-adrenergic agonists:a meta-analysis.Obstet Gynecol,2001,97(5 Pt 2):840 被引量：1
9[5]The Worldwide Atosiban versus Beta-agonists Study Group.Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour.The Worldwide Atosiban versus Beta-agonists Study Group.BJOG,2001,108(2):133 被引量：1
10[6]K Duckitt,S Thornton.Nitric oxide donors for the treatment of preterm labour (Cochrane Review).In:The Cochrane Library.Oxford:Update Software,2002. 被引量：1
